Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.

Shreya Gupta, Tahsin M Khan + Show 8 more

Open Access

https://doi.org/10.21037/jgo.2020.02.01

Copy DOI

Journal: Journal of gastrointestinal oncology	Publication Date: Apr 1, 2020
Citations: 9	License type: cc-by-nc-nd

Abstract

https://clinicaltrials.gov/ct2/show/NCT03801915?term=MVT&rank=3.

Full Text

Paper version not known

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author